Study of Circulating Blood Cell Monocytes as Predictive Biomarker of Bone Cystic Fibrosis Disease. Impact of CFTR Correctors.
NACompletedINTERVENTIONAL
Enrollment
25
Participants
Timeline
Start Date
April 25, 2018
Primary Completion Date
July 4, 2018
Study Completion Date
July 4, 2018
Conditions
Cystic Fibrosis
Interventions
BIOLOGICAL
Blood test
Blood draw (max 15 ml)
Trial Locations (1)
75014
Cochin Hospital, Paris
All Listed Sponsors
lead
Assistance Publique - Hôpitaux de Paris
OTHER
collaborator
Vaincre la Mucoviscidose
OTHER
NCT03492567 - Study of Circulating Blood Cell Monocytes as Predictive Biomarker of Bone Cystic Fibrosis Disease. Impact of CFTR Correctors. | Biotech Hunter | Biotech Hunter